These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2546376)

  • 1. Amphetamines: pharmacology, abuse and addiction.
    Miller NS; Millman RB; Gold MS
    Adv Alcohol Subst Abuse; 1989; 8(2):53-69. PubMed ID: 2546376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS stimulants and the look-alike drugs.
    Lake CR; Quirk RS
    Psychiatr Clin North Am; 1984 Dec; 7(4):689-701. PubMed ID: 6151645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
    Cunha-Oliveira T; Rego AC; Oliveira CR
    Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-the-counter stimulants: abuse and addiction.
    Tinsley JA; Watkins DD
    Mayo Clin Proc; 1998 Oct; 73(10):977-82. PubMed ID: 9787749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure.
    Barbier E; Pierrefiche O; Vaudry D; Vaudry H; Daoust M; Naassila M
    Neuropharmacology; 2008 Dec; 55(7):1199-211. PubMed ID: 18713641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing abuse liability during drug development: changing standards and expectations.
    Schoedel KA; Sellers EM
    Clin Pharmacol Ther; 2008 Apr; 83(4):622-6. PubMed ID: 18212799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine addiction as a neurological disorder: implications for treatment.
    Majewska MD
    NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 94():101-26. PubMed ID: 2514360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current thoughts about the mechanism of drug addiction and the possibility of development of new drugs in its treatment.
    De DP
    J Indian Med Assoc; 1994 Jul; 92(7):239-40. PubMed ID: 7963608
    [No Abstract]   [Full Text] [Related]  

  • 11. [The reality of drugs. Ecstasy, cannabis, crack].
    Pons D; Beauverie P; Touzeau D; Richard D; Fournier G; Mangon E; Charles-Nicolas A
    Soins; 1997; (612):26-32. PubMed ID: 9110884
    [No Abstract]   [Full Text] [Related]  

  • 12. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug abuse in Slovak Republic.
    Kresanek J; Plackova S; Caganova B; Klobusicka Z
    Przegl Lek; 2005; 62(6):357-60. PubMed ID: 16225068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO.
    Keup W
    Drug Alcohol Depend; 1986 Jun; 17(2-3):169-92. PubMed ID: 2874968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vascular effects of trace amines and amphetamines.
    Broadley KJ
    Pharmacol Ther; 2010 Mar; 125(3):363-75. PubMed ID: 19948186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychostimulants.
    Sanchez-Ramos JR
    Neurol Clin; 1993 Aug; 11(3):535-53. PubMed ID: 8104314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug abuse: a biopsychiatric model.
    Giannini AJ; Miller NS
    Am Fam Physician; 1989 Nov; 40(5):173-82. PubMed ID: 2573261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effects of central nervous system stimulants.
    Holman RB
    Addiction; 1994 Nov; 89(11):1435-41. PubMed ID: 7841853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An tale of two epidemics: HIV and stimulant use.
    Gorman M
    Focus; 1998 Mar; 13(4):1-3. PubMed ID: 11365170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mefenorex (Rondimen).
    Engel J; Kristen G; Schaefer A; von Schlichtegroll A
    Drug Alcohol Depend; 1986 Jun; 17(2-3):229-34. PubMed ID: 3743406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.